27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Alexion Pharmaceuticals (NASDAQ:ALXN) shares are trading lower on Tuesday, after the company reported the purchase of Portola Pharma for $18 per share in cash.
Alexion is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria.
Alexion shares traded down 5.45% at $98.18 at time of publication on Tuesday. The stock has a 52-week range between $137.52 and $72.67.
Related Link:
Alexion Confirms FDA Approval For Soliris
Alexion To Acquire Achillion Pharma For $930M
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!